Market Overview:
The global sacral neuromodulation system market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in sacral neuromodulation devices. Based on type, the global sacral neuromodulation system market is segmented into internal neuromodulation system and external neuromodulation system. The internal neuromodulation system segment is further sub-segmented into implantable pulse generators (IPGs) and leads. The external neurmoduation systems segment is further sub-segmented into wearable IPGs and non-wearable IPGs. Based on application, the global sacral neurtmation sytem market is divided into spinal cord stimulation (SCS), deep brain stimulation (DBS), sacral nerve stimulation (SNS), and vagus nerve stimualtion (VNS). Geographically, the global Sacal Neurmodualtion System Marketis analyzed across North America, Latin America, Europe Asia Pacific & Middle East Africa regions with a detailed analysis of each region by type and application.
Product Definition:
The sacral neuromodulation system is a nerve stimulation system used to treat urinary and fecal incontinence. The system consists of a stimulator, or pulse generator, which is implanted under the skin in the lower back, and leads which are inserted through the skin into the spinal canal. The stimulator sends electrical pulses to the sacral nerves, which control urination and defecation.
Internal Neuromodulation System:
The internal neuromodulation system, also known as the interfacing or intermodal interface system is a device that helps transfer information between different parts of brain. It's major function is to help people who have lost their ability to move and feel from one side of body due to stroke or any other reason. This device works on the principle that signals received by sensory nerves from body part need not go through motor nerve but can be processed in brain directly resulting in effective movement and feeling.
External Neuromodulation System:
External neuromodulation system is used in Sacral Neuromodulation System to modulate the sacral nerve. This device works by delivering electrical impulses to the nerves that are responsible for pain, and this helps in reducing or eliminating chronic pain.
The external neuromodulation system market is expected to witness lucrative growth over the forecast period owing to factors such as increasing prevalence of chronic diseases such as neurogenic bladder dysfunction, arthritis, lower back pain.
Application Insights:
On the basis of application, the market is segmented into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation and vagus nerve stimulation. In 2017, deep brainstimulation dominated the market with a share of over 40% in terms of revenue. This high share is attributable to increasing prevalence of neurological disorders that require surgical treatment and growing numberof approved applications for deep brainstimulation surgery across various regions including North America and Europe.
Sacral nerve stimulationshare is expected to grow at a lucrative rate during the forecast period owingto its non-invasive natureand minimally invasive procedures involved in itsapplication which have led to increased adoptionof this modality worldwide. The introductionof new technologies such as internalsacral neuromodulation system has further propelledthe growth prospects for this segment duringthe forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, increasing prevalence of chronic pain conditions, and rising awareness about sacral neuromodulation therapy. Moreover, growing number of patients undergoing surgery for disorders such as bladder obstruction or urinary retention and chronic constipation are some other factors driving the North America market. In addition, presence of key players in this region is also expected to boost growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to improving healthcare infrastructure and economic development coupled with government initiatives for improving quality of life.
Growth Factors:
- Increasing incidence of chronic lower back pain: The sacral neuromodulation system is used to treat chronic lower back pain. The increasing incidence of chronic lower back pain is expected to drive the growth of the sacral neuromodulation system market.
- Growing demand for minimally invasive procedures: The sacral neuromodulation system is a minimally invasive procedure and hence, its growing demand is expected to drive the growth of the market.
- Rising geriatric population: As people age, they are more likely to suffer from conditions such as chronic lower back pain that can be treated with a sacral neuromodulation system implantation procedure. This rising geriatric population is thus expected to fuel the growth of this market in coming years.
- Technological advancements: With technological advancements, new and improved devices are being launched in this market which offer better treatment outcomes for patients suffering from various conditions such as urinary incontinence and fecal incontinence among others .This will spur the growth of this market in coming years . 5)Growing awareness about available treatments options : There has been an increase in awareness about available treatments options for various medical conditions including those that can be treated with a sacral neuromodulator implantation procedure .This will help boost the sales of these devices and drives th egrowth o fthe sa cral neu roma dula tion sys tem ma rket
Scope Of The Report
Report Attributes
Report Details
Report Title
Sacral Neuromodulation System Market Research Report
By Type
Internal Neuromodulation System, External Neuromodulation System
By Application
Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation
By Companies
Medtronic, Inc. (US), Boston Scientific Corporation (US), St. Jude Medical, Inc. (US), Synapse Biomedical, Inc. (US), Nevro Corporation (US), Neurosigma, Inc. (US), Neuropace, Inc. (US), Neuronetics, Inc. (US), Cyberonics, Inc. (US), BioControl Medical (Israel)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
192
Number of Tables & Figures
135
Customization Available
Yes, the report can be customized as per your need.
Global Sacral Neuromodulation System Market Report Segments:
The global Sacral Neuromodulation System market is segmented on the basis of:
Types
Internal Neuromodulation System, External Neuromodulation System
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic, Inc. (US)
- Boston Scientific Corporation (US)
- St. Jude Medical, Inc. (US)
- Synapse Biomedical, Inc. (US)
- Nevro Corporation (US)
- Neurosigma, Inc. (US)
- Neuropace, Inc. (US)
- Neuronetics, Inc. (US)
- Cyberonics, Inc. (US)
- BioControl Medical (Israel)
Highlights of The Sacral Neuromodulation System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Internal Neuromodulation System
- External Neuromodulation System
- By Application:
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sacral Neuromodulation System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The sacral neuromodulation system (SNS) is a group of nerve cells and their associated circuitry located in the lower spinal cord. The SNS is responsible for controlling the activities of various muscles in the pelvic region, including those that support sexual function.
Some of the major players in the sacral neuromodulation system market are Medtronic, Inc. (US), Boston Scientific Corporation (US), St. Jude Medical, Inc. (US), Synapse Biomedical, Inc. (US), Nevro Corporation (US), Neurosigma, Inc. (US), Neuropace, Inc. (US), Neuronetics, Inc. (US), Cyberonics, Inc. (US), BioControl Medical (Israel).
The sacral neuromodulation system market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sacral Neuromodulation System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sacral Neuromodulation System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sacral Neuromodulation System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sacral Neuromodulation System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sacral Neuromodulation System Market Size & Forecast, 2018-2028
4.5.1 Sacral Neuromodulation System Market Size and Y-o-Y Growth
4.5.2 Sacral Neuromodulation System Market Absolute $ Opportunity
Chapter 5 Global Sacral Neuromodulation System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Sacral Neuromodulation System Market Size Forecast by Type
5.2.1 Internal Neuromodulation System
5.2.2 External Neuromodulation System
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Sacral Neuromodulation System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Sacral Neuromodulation System Market Size Forecast by Applications
6.2.1 Spinal Cord Stimulation
6.2.2 Deep Brain Stimulation
6.2.3 Sacral Nerve Stimulation
6.2.4 Vagus Nerve Stimulation
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sacral Neuromodulation System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sacral Neuromodulation System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Sacral Neuromodulation System Analysis and Forecast
9.1 Introduction
9.2 North America Sacral Neuromodulation System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Sacral Neuromodulation System Market Size Forecast by Type
9.6.1 Internal Neuromodulation System
9.6.2 External Neuromodulation System
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Sacral Neuromodulation System Market Size Forecast by Applications
9.10.1 Spinal Cord Stimulation
9.10.2 Deep Brain Stimulation
9.10.3 Sacral Nerve Stimulation
9.10.4 Vagus Nerve Stimulation
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Sacral Neuromodulation System Analysis and Forecast
10.1 Introduction
10.2 Europe Sacral Neuromodulation System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Sacral Neuromodulation System Market Size Forecast by Type
10.6.1 Internal Neuromodulation System
10.6.2 External Neuromodulation System
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Sacral Neuromodulation System Market Size Forecast by Applications
10.10.1 Spinal Cord Stimulation
10.10.2 Deep Brain Stimulation
10.10.3 Sacral Nerve Stimulation
10.10.4 Vagus Nerve Stimulation
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Sacral Neuromodulation System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Sacral Neuromodulation System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Sacral Neuromodulation System Market Size Forecast by Type
11.6.1 Internal Neuromodulation System
11.6.2 External Neuromodulation System
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Sacral Neuromodulation System Market Size Forecast by Applications
11.10.1 Spinal Cord Stimulation
11.10.2 Deep Brain Stimulation
11.10.3 Sacral Nerve Stimulation
11.10.4 Vagus Nerve Stimulation
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Sacral Neuromodulation System Analysis and Forecast
12.1 Introduction
12.2 Latin America Sacral Neuromodulation System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Sacral Neuromodulation System Market Size Forecast by Type
12.6.1 Internal Neuromodulation System
12.6.2 External Neuromodulation System
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Sacral Neuromodulation System Market Size Forecast by Applications
12.10.1 Spinal Cord Stimulation
12.10.2 Deep Brain Stimulation
12.10.3 Sacral Nerve Stimulation
12.10.4 Vagus Nerve Stimulation
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Sacral Neuromodulation System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Sacral Neuromodulation System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Sacral Neuromodulation System Market Size Forecast by Type
13.6.1 Internal Neuromodulation System
13.6.2 External Neuromodulation System
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Sacral Neuromodulation System Market Size Forecast by Applications
13.10.1 Spinal Cord Stimulation
13.10.2 Deep Brain Stimulation
13.10.3 Sacral Nerve Stimulation
13.10.4 Vagus Nerve Stimulation
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sacral Neuromodulation System Market: Competitive Dashboard
14.2 Global Sacral Neuromodulation System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic, Inc. (US)
14.3.2 Boston Scientific Corporation (US)
14.3.3 St. Jude Medical, Inc. (US)
14.3.4 Synapse Biomedical, Inc. (US)
14.3.5 Nevro Corporation (US)
14.3.6 Neurosigma, Inc. (US)
14.3.7 Neuropace, Inc. (US)
14.3.8 Neuronetics, Inc. (US)
14.3.9 Cyberonics, Inc. (US)
14.3.10 BioControl Medical (Israel)
